Latest News
FDA Approves Spinal Cord Stimulation Therapy for Painful Diabetic Neuropathy
Gender- and Ethnic-Specific Trends in Suicidality Among Adolescents in the US Between 1991-2019
Cardiovascular Drugs Do Not Impact COVID-19 Outcomes
Pfizer to Meet With US Officials About COVID-19 Booster Shot
Topical Lidocaine Gel Reduces Pain Scores and Opioid Use Consumption After Following Cardiac Surgery
Review Explores Risk for Early-Onset Stroke, Parkinson Disease With Methamphetamine Use
FDA Takes Steps to Maintain Supply of Smoking Cessation Therapy
Complications Develop in Half of COVID-19 Cases Treated in Hospitals
ACIP: Benefits of mRNA COVID-19 Vaccines Outweigh Risks for 12 and Up
Florida’s Restrictive Opioid Law HB21 Did Not Lead to Increased NSAID Prescriptions
Trajectories of Pain Symptoms From Early Childhood to Adolescence Impacted by Certain Distinct Life Experiences
Trigeminal Neuralgia: A Rare Facial Pain Condition Comprising 3 Distinct Subtypes
mRNA From COVID-19 Vaccines Not Detectable in Breast Milk
Nearly 4 in 10 With Mild COVID-19 Report Symptoms 7 Months Later
Latest Features
Management of COVID-19 in Transplant Recipients Evolved During Pandemic
Therapies used to treat COVID-19 in solid organ transplant recipients shifted since the pandemic began
Alcohol Withdrawal: Individualized Care and Pharmacologic Treatment
More than 50% of patients with alcohol use disorder develop alcohol withdrawal symptoms within hours of discontinuing or decreasing alcohol use.
Exploring Aspirin for the Treatment and Prevention of Migraines
Aspirin has been effective for acute migraines both as a solitary modality and in combination with other drugs, and thus has clinical value in treatment and prophylaxis of the migraines overall.
What Does the Future of the Mental Health Pandemic Hold?
With health experts across the country agreeing we are in the midst of a mental health pandemic, psychiatrist Aaron M. Hawkins, MD offers his view about the current state and the future of mental health in the United States.
Highlights of Virtual Congressional Briefing: Understanding the Immune Response to COVID-19
Panelists at a virtual congressional briefing, including James Kublin, MD, addressed critical questions about new diagnostic technologies, vaccine and treatment development, and the long-term impact of COVID-19 on patients who have recovered from the disease.
- Loading...
Loading...
Loading... 
Loading...